These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 34090928

  • 21. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
    Mikolasevic I, Domislovic V, Krznaric-Zrnic I, Krznaric Z, Virovic-Jukic L, Stojsavljevic S, Grgurevic I, Milic S, Vukoja I, Puz P, Aralica M, Hauser G.
    Medicina (Kaunas); 2022 Feb 08; 58(2):. PubMed ID: 35208576
    [Abstract] [Full Text] [Related]

  • 22. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.
    Vilar-Gomez E, Chalasani N.
    J Hepatol; 2018 Feb 08; 68(2):305-315. PubMed ID: 29154965
    [Abstract] [Full Text] [Related]

  • 23. Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    Peleg N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, Braun M, Shlomai A.
    PLoS One; 2018 Feb 08; 13(8):e0202393. PubMed ID: 30106985
    [Abstract] [Full Text] [Related]

  • 24. Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis.
    Ismaiel A, Leucuta DC, Popa SL, Fagoonee S, Pellicano R, Abenavoli L, Dumitrascu DL.
    Panminerva Med; 2021 Dec 08; 63(4):508-518. PubMed ID: 33165307
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, Deschenes M, Ghali P.
    PLoS One; 2015 Dec 08; 10(6):e0128774. PubMed ID: 26083565
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic performance of non-invasive liver fibrosis risk scores in biopsy-proven non-alcoholic fatty liver disease patients in India.
    Prasad M, Gupta S, Kashyap N, Kapil U.
    Indian J Gastroenterol; 2023 Apr 08; 42(2):192-198. PubMed ID: 37191918
    [Abstract] [Full Text] [Related]

  • 30. Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
    Ito T, Nguyen VH, Tanaka T, Park H, Yeh ML, Kawanaka M, Arai T, Atsukawa M, Yoon EL, Tsai PC, Toyoda H, Huang JF, Henry L, Jun DW, Yu ML, Ishigami M, Nguyen MH, Cheung RC.
    Clin Gastroenterol Hepatol; 2023 Apr 08; 21(4):1013-1022.e6. PubMed ID: 35654298
    [Abstract] [Full Text] [Related]

  • 31. Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores.
    Durazzo M, Marzari L, Bonetto S, Ferro A, Ghigo MC, Belci P, Collo A, Fagoonee S.
    Minerva Gastroenterol Dietol; 2020 Dec 08; 66(4):301-306. PubMed ID: 32700500
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds.
    Meneses D, Olveira A, Corripio R, Del Carmen Méndez M, Romero M, Calvo-Viñuelas I, Herranz L, Vicent D, de-Cos-Blanco AI.
    Obes Surg; 2020 Jul 08; 30(7):2538-2546. PubMed ID: 32157523
    [Abstract] [Full Text] [Related]

  • 34. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK, Kim W, Kim D, Kim JH, Oh S, Lee KL, Chang MS, Jung YJ, So YH, Lee MS, Bae JM, Kim BG.
    Liver Int; 2018 Feb 08; 38(2):331-341. PubMed ID: 28796410
    [Abstract] [Full Text] [Related]

  • 35. Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
    Zhou YJ, Ye FZ, Li YY, Pan XY, Chen YX, Wu XX, Xiong JJ, Liu WY, Xu SH, Chen YP, Zheng MH.
    United European Gastroenterol J; 2019 Oct 08; 7(8):1124-1134. PubMed ID: 31662869
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K, Thongprayoon C, Scribani M, Ungprasert P, Cheungpasitporn W.
    Eur J Gastroenterol Hepatol; 2018 Apr 08; 30(4):404-410. PubMed ID: 29215435
    [Abstract] [Full Text] [Related]

  • 40. Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Han S, Choi M, Lee B, Lee HW, Kang SH, Cho Y, Ahn SB, Song DS, Jun DW, Lee J, Yoo JJ.
    Gut Liver; 2022 Nov 15; 16(6):952-963. PubMed ID: 35193993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.